Literature DB >> 1999485

Vaccination with Legionella pneumophila membranes induces cell-mediated and protective immunity in a guinea pig model of Legionnaires' disease. Protective immunity independent of the major secretory protein of Legionella pneumophila.

S J Blander1, M A Horwitz.   

Abstract

We have examined the capacity of Legionella pneumophila membranes to induce cell-mediated immune responses and protective immunity in a guinea pig model of Legionnaires' disease. Guinea pigs immunized by aerosol with L. pneumophila membranes developed strong cell-mediated immune responses to L. pneumophila membranes as demonstrated by cutaneous delayed-type hypersensitivity and in vitro splenic lymphocyte proliferation. Guinea pigs immunized by aerosol or by subcutaneous inoculation with L. pneumophila membranes developed strong protective immunity against lethal aerosol challenge with L. pneumophila. Overall, in six independent experiments, 39 of 49 (80%) guinea pigs immunized with L. pneumophila membranes survived challenge compared with 2 of 40 (5%) sham-immunized controls (P = 2 x 10(-13). In contrast, guinea pigs immunized by aerosol with formalin-killed L. pneumophila did not develop either a strong cell-mediated immune response to L. pneumophila antigens or protective immunity to lethal aerosol challenge. The capacity of L. pneumophila membranes to induce protective immunity was independent of the major secretory protein of L. pneumophila, which we previously demonstrated is an immunoprotective molecule. Purified L. pneumophila membranes did not contain detectable major secretory protein (MSP) on immunoblots; immunization of guinea pigs with L. pneumophila membranes did not induce anti-MSP antibody; and guinea pigs developed comparable protective immunity after immunization with membranes from either an L. pneumophila strain that secretes the major secretory protein or an isogenic mutant that does not. This study demonstrates that (a) immunization with L. pneumophila membranes but not formalin-killed L. pneumophila induces strong cell-mediated immune responses and protective immunity, (b) L. pneumophila membranes contain immunoprotective molecules distinct from the major secretory protein of L. pneumophila, and (c) L. pneumophila membranes have potential as a vaccine against Legionnaires' disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1999485      PMCID: PMC329900          DOI: 10.1172/JCI115065

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Electron microscopic examination of the inflammatory response to Legionella pneumophila in guinea pigs.

Authors:  S M Katz; S Hashemi
Journal:  Lab Invest       Date:  1982-01       Impact factor: 5.662

3.  An immunoprotective molecule, the major secretory protein of Legionella pneumophila, is not a virulence factor in a guinea pig model of Legionnaires' disease.

Authors:  S J Blander; L Szeto; H A Shuman; M A Horwitz
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

4.  Experimental transmission of legionnaires' disease by exposure to aerosols of Legionella pneumophila.

Authors:  A Baskerville; R B Fitzgeorge; M Broster; P Hambleton; P J Dennis
Journal:  Lancet       Date:  1981 Dec 19-26       Impact factor: 79.321

5.  Legionnaires' disease bacterium (Legionella pneumophila) multiples intracellularly in human monocytes.

Authors:  M A Horwitz; S C Silverstein
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

6.  Legionnaires' pneumonia after aerosol exposure in guinea pigs and rats.

Authors:  G S Davis; W C Winn; D W Gump; J E Craighead; H N Beaty
Journal:  Am Rev Respir Dis       Date:  1982-12

7.  Dose-response of guinea pigs experimentally infected with aerosols of Legionella pneumophila.

Authors:  R F Berendt; H W Young; R G Allen; G L Knutsen
Journal:  J Infect Dis       Date:  1980-02       Impact factor: 5.226

8.  Activated human monocytes inhibit the intracellular multiplication of Legionnaires' disease bacteria.

Authors:  M A Horwitz; S C Silverstein
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

9.  Interaction of the Legionnaires' disease bacterium (Legionella pneumophila) with human phagocytes. I. L. pneumophila resists killing by polymorphonuclear leukocytes, antibody, and complement.

Authors:  M A Horwitz; S C Silverstein
Journal:  J Exp Med       Date:  1981-02-01       Impact factor: 14.307

10.  Interaction of the legionnaires' disease bacterium (Legionella pneumophila) with human phagocytes. II. Antibody promotes binding of L. pneumophila to monocytes but does not inhibit intracellular multiplication.

Authors:  M A Horwitz; S C Silverstein
Journal:  J Exp Med       Date:  1981-02-01       Impact factor: 14.307

View more
  11 in total

1.  Legionella pneumophila contains a type II general secretion pathway required for growth in amoebae as well as for secretion of the Msp protease.

Authors:  L M Hales; H A Shuman
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

Review 2.  Molecular pathogenesis of infections caused by Legionella pneumophila.

Authors:  Hayley J Newton; Desmond K Y Ang; Ian R van Driel; Elizabeth L Hartland
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

3.  In vivo regulation of replicative Legionella pneumophila lung infection by endogenous interleukin-12.

Authors:  J K Brieland; D G Remick; M L LeGendre; N C Engleberg; J C Fantone
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

4.  Major cytoplasmic membrane protein of Legionella pneumophila, a genus common antigen and member of the hsp 60 family of heat shock proteins, induces protective immunity in a guinea pig model of Legionnaires' disease.

Authors:  S J Blander; M A Horwitz
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

5.  Interferon-gamma (IFN-gamma) production by human T lymphocytes upon Legionella pneumophila stimulation in vitro.

Authors:  K Kitsukawa; A Nakamoto; H Koito; Y Matsuda; A Saito; H Yamamoto
Journal:  Clin Exp Immunol       Date:  1995-01       Impact factor: 4.330

6.  Human and guinea pig immune responses to Legionella pneumophila protein antigens OmpS and Hsp60.

Authors:  R Weeratna; D A Stamler; P H Edelstein; M Ripley; T Marrie; D Hoskin; P S Hoffman
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

Review 7.  The guinea pig as a model of infectious diseases.

Authors:  Danielle J Padilla-Carlin; David N McMurray; Anthony J Hickey
Journal:  Comp Med       Date:  2008-08       Impact factor: 0.982

8.  Mice immunized with a chlamydial extract have no increase in early protective immunity despite increased inflammation following genital infection by the mouse pneumonitis agent of Chlamydia trachomatis.

Authors:  S J Blander; A J Amortegui
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

9.  Secondary immunity to Legionella pneumophila and Th1 activity are suppressed by delta-9-tetrahydrocannabinol injection.

Authors:  C A Newton; T W Klein; H Friedman
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

10.  Dynamics of peripheral blood lymphocyte subpopulations in the acute and subacute phase of Legionnaires' disease.

Authors:  Cornelis P C de Jager; Eugenie F A Gemen; Jacqueline Leuvenink; Mirrian Hilbink; Robert J F Laheij; Tom van der Poll; Peter C Wever
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.